Depot Characteristics and Biodistribution of Interleukin-2 Liposomes, Importance of Route of Administration

Peter M. Anderson(Mayo Clinic in Arizona), Bruce Bostrom(Minnesota West Community & Technical College), Augusto C. Ochoa(Stanley Foundation), Susan Sencer(University of Minnesota Children's Hospital), Emmanuel Katsanis(University of Arizona), Diane E. Hasz(University of Minnesota)

Journal of Immunotherapy

July 1, 1992

10.1097/00002371-199207000-00003

Cited by 60

Related Papers

Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses

|Cancer Research|2004|1.2k

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

|Cancer Immunology Research|2015|570

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1987|334